Malignant pheochromocytoma. Case report and observations on this rare pathology

Minerva Chirurgica

Volumn 54, Issue 1-2, 1999, Pages 73-78

  Boneschi, M ^a   Erba, M ^a   Rinaldi, P ^a   Cusmai, F ^a   Miani, S ^a  

^a NONE

Author keywords

Adrenal gland neoplasms; Paraganglioma; Pheochromocytoma

Indexed keywords

CATECHOLAMINE; DOPAMINE; IODINE 131; NEUROPEPTIDE;

ADRENAL MEDULLA; ADRENAL TUMOR; ARTICLE; CANCER INVASION; CASE REPORT; CATECHOLAMINE URINE LEVEL; CHEMODECTOMA; DOPAMINE URINE LEVEL; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MITOSIS RATE; NEURAL CREST; PARAGANGLIOMA; PHEOCHROMOCYTOMA; SCINTISCANNING; SYMPATHETIC GANGLION; ADULT; FEMALE; PATHOLOGY; REVIEW;

ADRENAL GLAND NEOPLASMS; ADULT; FEMALE; HUMANS; LYMPHATIC METASTASIS; PHEOCHROMOCYTOMA;

EID: 0032604027     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kliewer KE, Cochran AJ. A review of the histology, ultrastucture immunohistology and molecular biology of extra-adrenal paragangliomas. Arch Pathol Lab Med 1989;113:1209-17.
2. Proye C, Fossati P, Fontaine P, Lefevre J, Decoulx M, Wemeau JL. Dopamine-secreting pheochromocytoma: An unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 1986;100-6:1154-62.
3. Khafagi FA, Shapiro B, Fischer M. Pheochromocytoma and functioning paraganglioma in children and adolescence: role of iodine 131 MIBG. Eur J Nucl Med 1991;18:191-8.
4. Lack EE, Cubilla A, Woodruff JM, Liebermann P. Extraadrenal paragangliomas of the retroperitoneum: a clinicopathologic study of 12 tumors. Am J Surg Pathol 1980;4:109.
5. Das S, Lowe P. Malignant pheochromocytoma of the bladder. J Urol 1980;123:282.
6. Yoffa DE, Withycombe JFR. Bladder pheochromocytoma metastases. Lancet 1967;2:422.
7. Melicow MM. One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center 1926-1976. A clinicopathological analysis. Cancer 1977;40:1987-2004.
8. Medeiros LJ, Wolf BC, Balogh K. Adrenal pheochromocytoma: a clinicopathologic review of 66 cases. Hum Pathol 1985;16:580-9.
9. Hauss J, Pircher W, Spiegel HU, Kertelge E. Pheochromozytombehandlung: Wandel von Diagnostik und therapie. Acta Med Austr 1988;4:95.
10. Proye C, Vix M, Goropoulos A, Kerlo P, LeCompte-Houcke M. High incidence of malignant pheochromocytoma in a surgical unit, 26 cases out of 100 patients operated from 1971 to 1991. J Endocrinol Invest 1992;15:651-63.
11. Linnoila RI, Keiser HR, Steimberg SM, Lack EE. Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol 1990;21:1168.
12. Glenn F, Gray GF. Functional tumors of the organ of Zuckerkandl. Arch Surg 1976;183:578-86.
13. Serrano PA, Chevez-Laba B, Sanchez-Torres J. Dopamine excretion in benign pheochromocytoma. Biomedicine 1978;29:229.
14. Vinik AI, Shapiro B, Thompson NW. Plasma gut hormone levels in 37 patients with pheochromocytomas. World J Surg 1986;10:593.
15. Lloyd RV, Shapiro B, Sisson JC, Kalff V, Thompson NW, Beierwaltes WD. An immunohistochemical study of pheochromocytomas. Arch Pathol Lab Med 1984; 108:541.
16. Linnoila RI, Lack EE, Steimberg S, Keiser HR. Decreased expression of neuropeptides in malignant paragangliomas: An immunohistochemical study. Hum Pathol 1988;19:47-50.
17. Hosaka Y, Rainwater LH, Grant CS, Farrow GM, Van Heerden JA, Lieber MA. Pheochromocytoma: nuclear deoxyribonucleic acid pattern by flow cytometry. Surgery 1986;100:1003.
18. Ambreson JB, Vaughan ED, Gray GF. Flow cytometric determination of nuclear DNA content in benign adrenal pheochromocytomas. Urology 1987;30:102-4.
19. Montresor E, Iacono C, Nifoi E, Zanza A, Modena S, Zamboni G et al. Retroperitoneal Paragangliomas: role of Immunohistochemistry in the diagnosis of malignancy and assessment of prognosis. Eur J Surg 1994; 160:547-52.
20. Achilles EA, Padberg C, Holl K, Kloppel G, Schroder S. Immunocytochemistry of paragangliomas value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis. Histopathology 1991;18: 453-8.
21. Pelosi G, Zamboni G, Doglioni C, Rodella S, Bresaola E, Iacono C et al. Immunodetection of proliferating cell nuclear antigen assesses the growth fraction and predicts malignancy in endocrine tumors of the pancreas. Am J Surg Pathol 1992;16(12):1215-25.
22. Gerdes J, Li L, Schlueter C. Immunobiochemical and molecular biologic cheracterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki67. Am J Pathol 1991;138:867-73.
23. Van Heerden JA, Roland CF, Carney A, Sheps SG, Grant CS. Long term evaluation following resection of apparently benign pheochromocytomas/paragangliomas. World J Surg 1990;14:325-9.